Denis Ribon

Denis Ribon

Chairman - Managing Partner

Denis has over 25 years of experience in the Healthcare sector. Denis started his career as a veterinarian and subsequently worked for management consulting firm AT Kearney. In 2001, Denis joined Private Equity leader 3i and became the global head of the Healthcare team in 2007, overseeing the company’s Healthcare investments and portfolio across Europe, North America and Asia (China, India, Singapore).

Denis actively contributed to the development and strategic growth of companies in various Healthcare sectors. He served as a Board Chairman or Director in more than 25 public and private healthcare companies, including Quintiles (now Iqvia), Labco (now Synlab), iPP (now Synlab), Vétoquinol or Carso, operating in all types of Healthcare sub-sectors.

Denis is a Founding Partner of ArchiMed. He is also a Director of the Eureka Foundation, ArchiMed’s charitable foundation. Denis has a long-standing relationship with other ArchiMed partners, for more than 20 years. He is a member of the Healthcare taskforce of the Institut Montaigne, a leading independent think tank. Denis is currently a non-executive Director in the France-headquartered Gene & Cell Therapy specialist firm Polyplus and in the France-headquartered Specialty Pharma company Provepharm. He also was a non-executive Director in the France-headquartered Neuro-Diagnostic company Micromed, in the Switzerland-headquartered Trauma Orthopaedics company Medistream / Citieffe and in the UK-headquartered Life Sciences consulting firm Deallus operating at global level. Denis is the Chairman of ArchiMed and head of ArchiMed’s Management Committee.

Denis graduated from Vet Agro Sup, the French Veterinary University of Lyon and holds an MBA from HEC Paris. Denis is a French citizen.